Ocular Chloramphenicol Exposure in Early Childhood in Aotearoa/New Zealand

I. M. Y. Cheung, Simon Horsburgh, Ewan Smith, Samantha Simkin, A. Gokul
{"title":"Ocular Chloramphenicol Exposure in Early Childhood in Aotearoa/New Zealand","authors":"I. M. Y. Cheung, Simon Horsburgh, Ewan Smith, Samantha Simkin, A. Gokul","doi":"10.3390/pharma3020014","DOIUrl":null,"url":null,"abstract":"Background: The paediatric use of ophthalmic chloramphenicol in New Zealand (NZ) is relatively high; however, little more is known about its utilisation, including whether this is equitable. This study aimed to describe chloramphenicol utilisation in NZ children aged five years and under, by patient ethnicity, socioeconomic deprivation, and urban/non-urban domicile. Methods: This analysis included every publicly subsidised chloramphenicol dispensing received from birth to five years of age, for every child born in NZ in 2013. Cumulative proportion of first exposure, dispensing rate per person-year, and seasonality of dispensing were quantified. These were calculated following stratification by ethnicity, socioeconomic deprivation quintile, and urban/non-urban health district. For cumulative proportion of first exposure, odds ratios (OR) were calculated and multivariate logistic regression was performed. For dispensing rate, incidence rate ratios (IRR) were calculated and zero-inflated Poisson regression was performed. Results: Almost one-quarter of NZ children received their first dispensing within the first year of life. By five years of age, 55.2% of children had received their first dispensing. By five years of age, children of Pacific ethnicity, those in the highest deprivation quintile, and in those non-urban health districts had lower odds of receiving chloramphenicol (adjusted OR 0.90, 0.79, and 0.81, respectively, all p < 0.001). In contrast, children of Māori ethnicity had higher odds (adjusted OR 1.99, p < 0.001). Māori and Pacific ethnicity, and residence in non-urban health districts, were associated with fewer dispensings (adjusted IRR 0.88, 0.75 and 0.87, all p < 0.001). In contrast, deprivation quintile was not significantly associated with dispensing rate. Conclusion: Chloramphenicol utilisation is prevalent among NZ children, and utilisation may be lower among children of Pacific ethnicity and those in non-urban areas","PeriodicalId":503495,"journal":{"name":"Pharmacoepidemiology","volume":"22 8","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacoepidemiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/pharma3020014","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The paediatric use of ophthalmic chloramphenicol in New Zealand (NZ) is relatively high; however, little more is known about its utilisation, including whether this is equitable. This study aimed to describe chloramphenicol utilisation in NZ children aged five years and under, by patient ethnicity, socioeconomic deprivation, and urban/non-urban domicile. Methods: This analysis included every publicly subsidised chloramphenicol dispensing received from birth to five years of age, for every child born in NZ in 2013. Cumulative proportion of first exposure, dispensing rate per person-year, and seasonality of dispensing were quantified. These were calculated following stratification by ethnicity, socioeconomic deprivation quintile, and urban/non-urban health district. For cumulative proportion of first exposure, odds ratios (OR) were calculated and multivariate logistic regression was performed. For dispensing rate, incidence rate ratios (IRR) were calculated and zero-inflated Poisson regression was performed. Results: Almost one-quarter of NZ children received their first dispensing within the first year of life. By five years of age, 55.2% of children had received their first dispensing. By five years of age, children of Pacific ethnicity, those in the highest deprivation quintile, and in those non-urban health districts had lower odds of receiving chloramphenicol (adjusted OR 0.90, 0.79, and 0.81, respectively, all p < 0.001). In contrast, children of Māori ethnicity had higher odds (adjusted OR 1.99, p < 0.001). Māori and Pacific ethnicity, and residence in non-urban health districts, were associated with fewer dispensings (adjusted IRR 0.88, 0.75 and 0.87, all p < 0.001). In contrast, deprivation quintile was not significantly associated with dispensing rate. Conclusion: Chloramphenicol utilisation is prevalent among NZ children, and utilisation may be lower among children of Pacific ethnicity and those in non-urban areas
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
奥特亚罗瓦/新西兰幼儿眼部氯霉素暴露情况
背景:在新西兰,儿童眼科氯霉素的使用率相对较高;然而,人们对其使用情况知之甚少,包括是否公平。本研究旨在根据患者的种族、社会经济贫困程度以及城市/非城市户籍,描述新西兰五岁及以下儿童使用氯霉素的情况。方法:这项分析包括2013年新西兰出生的所有儿童从出生到5岁期间接受的每一次政府补贴的氯霉素配药。对首次接触的累积比例、每人每年的配药率以及配药的季节性进行了量化。这些数据是按照种族、社会经济贫困五分位数和城市/非城市卫生区进行分层后计算得出的。对于首次接触的累积比例,计算了几率比(OR),并进行了多变量逻辑回归。对于配药率,计算了发病率比(IRR),并进行了零膨胀泊松回归。结果显示近四分之一的新西兰儿童在出生后第一年内接受了首次配药。到 5 岁时,55.2% 的儿童接受了首次配药。到五岁时,太平洋岛屿族裔儿童、贫困程度最高的五分之一人口中的儿童以及非城市卫生区的儿童接受氯霉素治疗的几率较低(调整后的OR值分别为0.90、0.79和0.81,均小于0.001)。相比之下,毛利族儿童接受氯霉素治疗的几率更高(调整后的OR值为1.99,p < 0.001)。毛利族和太平洋岛屿族裔以及居住在非城市卫生区与配药次数较少有关(调整后内部收益率分别为0.88、0.75和0.87,均为p < 0.001)。相比之下,贫困五分位数与配药率无明显关联。结论氯霉素的使用在新西兰儿童中很普遍,太平洋族裔儿童和非城市地区儿童的使用率可能较低。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Ocular Chloramphenicol Exposure in Early Childhood in Aotearoa/New Zealand Treatment Patterns, Effectiveness, and Safety of Originator Insulin Glargine versus Insulin Glargine-yfgn within the Veterans Health Administration Opioid Prescribing for Noncancer Patients—Issues of Drug Therapy Safety: Results from a German Study Based on Routine Data Crises in Antimicrobial Stewardship: Misuse of Clarithromycin for Helicobacter pylori Therapy Rescue Therapy for Supratherapeutic Concentrations of Calcineurin Inhibitors Using Potent Cytochrome P450 Inducers
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1